Investigational drugs
If a researcher both designs a study and administers the substance, do they have extra legal responsibilities?
Plain English first, then the primary source. Education, not legal advice.
Interpretation
In short: taking on both roles means taking on both sets of duties, including reporting, recordkeeping, and oversight.
Plain English
FDA regulations recognize a role called sponsor-investigator, someone who both initiates and conducts a clinical investigation and under whose direction an investigational drug is administered. This person takes on the combined obligations of a sponsor, such as IND submission and safety reporting, and of an investigator, such as following the protocol and protecting participants.
This dual role carries more responsibility than either role alone, because there is no separate sponsor organization providing oversight, quality systems, or a check on the investigator's judgment.
FDA has published specific guidance recognizing that sponsor-investigators, often researchers in academic or small-scale settings, need clear information about which obligations fall on them personally.
Why it matters
- Independent researchers running their own small studies with RUO compounds are exactly the audience most likely to unknowingly take on sponsor-investigator obligations.
Where the answer becomes fact-specific
The Foundation does not manufacture legal conclusions. These points change the analysis and may require qualified regulatory counsel.
- Whether someone is legally a sponsor-investigator depends on their actual role in initiating, funding, and conducting the study, not their job title.